• ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Average Recommendation of "Buy" by Analysts

    المصدر: Buzz FX / 11 فبراير 2025 02:51:10   America/New_York


    ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Average Recommendation of "Buy" by Analysts Written by MarketBeat February 11, 2025 Share Link copied to clipboard. Shares of ARS Pharmaceuticals, Inc. ( NASDAQ:SPRY - Get Free Report ) have bee
    Read more...
شارك على،